Product Images Amlodipine Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Amlodipine Besylate NDC 43353-251 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description for a medication package of Amlodipine Besylate tablets with a strength of 5mg and a quantity of 15 tablets. The package has a NoC number and a code named "Asaasis". The package was sold for either $23 or $28.*
This appears to be output from a statistical analysis of some event data. The "P-value=0.003" suggests that there is strong evidence of a statistically significant difference between the groups being compared. The "Hazard Ratio=0691" suggests that the risk of the event occurring is lower in one group compared to the other. The "95% Cl=(0.54, 0.88)" provides a confidence interval for the hazard ratio. The time points listed could indicate the duration of the study or the time at which events occurred. Overall, this appears to be a summary of the statistical results from an event study.*
This text provides a summary of a study that compares the effectiveness of Favars Amladipine to Placebo in patients with baseline sitting SEP of 120 mmHig for various factors such as Gender, Baseline Vessel Disease, etc. The study includes 984 males and 334 females, with multiple baseline vessel diseases found in 1315 patients, amongst others. The results are presented in a graph that depicts the hazard ratio with a 95% confidence interval for different time intervals.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.